Stephanie Birkhimer, RPH | |
1451 Scalp Ave, Johnstown, PA 15904-3334 | |
(814) 269-3630 | |
Not Available |
Full Name | Stephanie Birkhimer |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1451 Scalp Ave, Johnstown, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104580448 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RP040978L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephanie Birkhimer, RPH 1451 Scalp Ave, Johnstown, PA 15904-3334 Ph: (814) 269-3630 | Stephanie Birkhimer, RPH 1451 Scalp Ave, Johnstown, PA 15904-3334 Ph: (814) 269-3630 |
News Archive
Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.
According to a thorough review published by Cochrane Researchers, commonly prescribed antidepressant drugs cannot be recommended for those suffering from autistic spectrum disorders based on current evidence. They say that there may be benefits of antidepressants in adults diagnosed with autism but similar benefits are not seen in children. These children may suffer extremely adverse effects if they consume selective serotonin reuptake inhibitors (SSRIs).
From tomorrow, Australian people who have chronic diseases and complex health conditions will have access to additional Medicare rebates for up to five allied health and three dental services.
CTA correctly detected the ruptured aneurysm in 170 cases when compared to intraoperative findings, Bijal Patel, MD, lead author of the study. Of the 22 cases where there was more than one aneurysm, CTA correctly identified the ones that were ruptured every time.
Cyanotech Corporation has been notified by the Nasdaq Listing Qualifications Panel that it is not in compliance with its continued listing requirements under Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2)(A) due to having only three independent directors of six total directors on its Board and fewer than three independent directors on its audit committee, while David I. Rosenthal serves as Interim President and CEO, as announced on March 1, 2010.
› Verified 1 days ago
Amanda Ann Gorzelsky, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1086 Franklin Street, Johnstown, PA 15906 Phone: 814-534-9000 | |
Dr. Daniel James Yost Iii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1759 Goucher St, Johnstown, PA 15905 Phone: 814-255-6001 | |
Brian Lux, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2470 Bedford St, Johnstown, PA 15904 Phone: 814-266-5150 | |
Andrea Ghezzi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2470 Bedford St, Johnstown, PA 15904 Phone: 814-266-5150 | |
David Scott Claycomb, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 942 Carnegie Ave, Johnstown, PA 15905 Phone: 814-341-6615 | |
Brittany Bonneau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 Scalp Ave, Johnstown, PA 15904 Phone: 814-266-9631 | |
Rachel Gipe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1932 William Penn Ave, Johnstown, PA 15909 Phone: 814-322-1011 |